CCEL

MKT CAP:$28M

Cryo-Cell International, Inc.

Market Cap

$28M

Healthcare·Medical - Care Facilities·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$3.67+$0.24 (+7.00%)

Apr 23, 2026

Company Details

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a...

CEO

David I. Portnoy

IPO Date

Apr 4, 1994

Website

www.cryo-cell.com

Key Metrics TTM

Revenue

$32M

-0.7% YoY

Net Income

-$1M

EPS (Diluted)

-$0.15

Free Cash Flow

$4M

Revenue / Share

$3.92

Gross Margin

77.4%

Operating Margin

10.1%

Net Margin

-3.7%

FCF Margin

13.1%

P/S

0.9x

P/E

—

Earnings Reports

Q1 2026

Apr 14, 2026

NEW

$8M-3.6%EPS $0.01

FY 2025

Feb 27, 2026

$32M-1.3%EPS -$0.30

Q2 2025

Jul 15, 2025

$8M-1.4%EPS $0.04

Q1 2025

Apr 14, 2025

$8M+1.5%EPS $0.03

FY 2024

Feb 28, 2025

$32M+2.0%EPS $0.05

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$7M	$5M	-$823.5K
Q1 22	$7M	$5M	$1M
Q2 22	$8M	$5M	$1M
Q3 22	$8M	$5M	$1M
Q4 22	$8M	$6M	$581.7K
Q1 23	$8M	$6M	$2M
Q2 23	$8M	$6M	$1M
Q3 23	$8M	$6M	$1M
Q4 23	$8M	$6M	-$16M
Q1 24	$8M	$6M	$821.2K
Q2 24	$8M	$6M	$1M
Q3 24	$8M	$6M	$1M
Q4 24	$8M	$6M	-$122.3K
Q1 25	$8M	$6M	$1M
Q2 25	$8M	$6M	$1M
Q1 26	$8M	$6M	$765.1K

Valuation

Quarter	P/S	P/E
Q4 21	3.6x	50.1x
Q1 22	2.3x	30.9x
Q2 22	1.7x	30.1x
Q3 22	1.9x	43.4x
Q4 22	1.3x	13.9x
Q1 23	1.1x	12.0x
Q2 23	1.3x	17.7x
Q3 23	1.5x	19.2x
Q4 23	1.3x	—
Q1 24	1.3x	—
Q2 24	2.1x	—
Q3 24	1.7x	—
Q4 24	2.2x	171.7x
Q1 25	1.7x	421.9x
Q2 25	1.3x	—
Q1 26	0.8x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	$2M	$1M
Q1 22	$2M	-$4M
Q2 22	$2M	$2M
Q3 22	$3M	-$9M
Q4 22	$2M	$2M
Q1 23	$2M	$1M
Q2 23	$2M	$131.7K
Q3 23	$2M	-$1M
Q4 23	$3M	$1M
Q1 24	-$356.9K	-$814.6K
Q2 24	$2M	-$911.8K
Q3 24	$2M	$2M
Q4 24	$2M	$2M
Q1 25	$954.1K	$892.0K
Q2 25	$707.0K	$644.6K
Q1 26	$651.8K	$584.8K

Capital Expenditures

Quarter	CapEx
Q4 21	$290.9K
Q1 22	$6M
Q2 22	$307.0K
Q3 22	$11M
Q4 22	$25.0K
Q1 23	$375.6K
Q2 23	$2M
Q3 23	$3M
Q4 23	$2M
Q1 24	$457.7K
Q2 24	$3M
Q3 24	$319.0K
Q4 24	$141.7K
Q1 25	$62.1K
Q2 25	$62.4K
Q1 26	$67.1K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	-3.0%	+51.8%
Q1 22	+5.8%	+2.9%
Q2 22	+5.9%	+23.6%
Q3 22	+2.4%	+6.9%
Q4 22	+6.1%	-11.8%
Q1 23	+7.8%	+6.1%
Q2 23	+1.8%	+4.8%
Q3 23	+2.5%	+6.3%
Q4 23	+1.5%	+234.9%
Q1 24	+0.4%	+14.5%
Q2 24	+3.5%	-1.4%
Q3 24	+2.5%	-0.5%
Q4 24	+1.9%	-66.1%
Q1 25	+1.5%	-1.7%
Q2 25	-1.4%	-3.2%
Q1 26	-4.8%	+3.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$67.7K	0.9%
Q1 22	$31.9K	0.4%
Q2 22	$117.5K	1.5%
Q3 22	$161.1K	2.1%
Q4 22	$150.9K	1.9%
Q1 23	$313.2K	4.0%
Q2 23	$156.4K	2.0%
Q3 23	$172.1K	2.2%
Q4 23	$174.9K	2.2%
Q1 24	$307.4K	3.9%
Q2 24	$178.1K	2.2%
Q3 24	$145.9K	1.8%
Q4 24	$149.7K	1.9%
Q1 25	$297.4K	3.7%
Q2 25	$0	0.0%
Q1 26	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 21	$19.4K	—	$5M
Q1 22	$147.2K	—	$3M
Q2 22	$80.9K	—	$4M
Q3 22	$80.3K	—	$4M
Q4 22	$76.4K	—	$5M
Q1 23	$78.8K	—	$4M
Q2 23	$304.7K	—	$4M
Q3 23	$344.1K	—	$4M
Q4 23	$443.8K	—	$5M
Q1 24	$502.9K	—	$4M
Q2 24	$241.1K	—	$4M
Q3 24	$193.9K	—	$4M
Q4 24	$304.6K	—	$6M
Q1 25	$98.1K	—	$5M
Q2 25	$131.7K	$4M	—
Q1 26	$65.8K	—	$5M

Revenue Segments

Quarter	Processing And Storage Fees	Product	Public Banking
Q4 21	$7M	$55.2K	$86.9K
Q1 22	$7M	$18.2K	$82.8K
Q2 22	$7M	$36.4K	$116.7K
Q3 22	$8M	$21.0K	$137.8K
Q4 22	$8M	$28.4K	$124.2K
Q1 23	$8M	$32.2K	$230.7K
Q2 23	$8M	$27.2K	$163.8K
Q3 23	$8M	$2.5K	$4.4K
Q4 23	$8M	$4.5K	$82.3K
Q1 24	$8M	$3.0K	$43.7K
Q2 24	$8M	$35.8K	$41.5K
Q3 24	$8M	$636	$120.6K
Q4 24	$8M	$28.4K	$160.9K
Q1 25	$8M	$20.9K	$82.1K
Q2 25	$8M	$14.4K	$42.7K
Q1 26	$8M	$38.6K	$1.4K

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 22	$3M	$63.1K	$3M
Q3 22	$3M	$38.7K	$3M
Q4 22	$2M	$17.6K	$2M
Q1 23	$1M	$840.3K	$2M
Q2 23	$1M	$568.2K	$2M
Q3 23	$584.0K	$623.5K	$1M
Q4 23	$406.1K	$574.2K	$980.3K
Q1 24	$247.1K	$732.5K	$979.6K
Q2 24	$469.2K	$1M	$2M
Q3 24	$197.4K	$2M	$2M
Q4 24	$561.0K	$3M	$3M
Q1 25	$223.1K	$3M	$3M
Q2 25	$137.5K	$4M	$4M
Q3 25	$265.2K	$3M	$3M
Q4 25	$319.0K	$3M	$3M
Q1 26	$249.7K	$3M	$3M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	9M	0.0%	+15.2%
Q1 22	9M	+0.6%	+6.7%
Q2 22	9M	-2.2%	+3.4%
Q3 22	8M	-1.7%	-3.3%
Q4 22	8M	+0.9%	-2.4%
Q1 23	8M	-0.5%	-3.5%
Q2 23	8M	-1.3%	-2.6%
Q3 23	8M	+0.1%	-0.7%
Q4 23	8M	-0.0%	-1.7%
Q1 24	8M	-1.0%	-2.2%
Q2 24	8M	-0.3%	-1.2%
Q3 24	8M	-0.7%	-2.0%
Q4 24	8M	+0.5%	-1.5%
Q1 25	8M	-0.2%	-0.7%
Q2 25	8M	-0.9%	-1.3%
Q1 26	8M	-0.9%	-1.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$88.1K	83
Q1 22	$87.5K	83
Q2 22	$92.0K	83
Q3 22	$92.5K	83
Q4 22	$97.1K	80
Q1 23	$97.8K	80
Q2 23	$97.2K	80
Q3 23	$98.4K	80
Q4 23	$96.1K	82
Q1 24	$95.8K	82
Q2 24	$98.1K	82
Q3 24	$98.4K	82
Q4 24	$97.9K	82
Q1 25	$97.2K	82
Q2 25	$96.7K	82
Q1 26	$106.7K	72

Revenue / Employee